CoRegen (Series)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
July 9, 2025
Vertical
Biopharmaceutical
Funding URL
View Funding Page
Funding Amount
$93,390,000
Company Info
Market
Cancer treatment
Location
Houston, Texas, USA
Company Description

CoRegen is a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of cancer.

Links
Back to HomeBack to Biopharmaceutical DealsView Funding Announcement